Integra has completed their internal investigation on 03/01/2016.The investigation included: methods: evaluation of actual device.Review of device history records.Review of complaint history.Results: evaluation of device: one duraseal sealant system 5ml (qty 5) us was received opened by the account with the appropriate blister package in an undamaged condition.The visual inspection of the powder vial noted the product to be partially prepared.Further inspection noted that the powder vial cap had been completely recessed.The powder vial had blue residue indicating that the precursor solution had been fully injected and mixed.The blue precursor syringe was received engaged with the powder vial cap and had blue residue inside indicating that the mixed solution was drawn out of the powder vial.There was no evidence of polymer inside the syringes.The clear precursor was returned with approximately 2.5ml of liquid solution.A review of the device history record indicates this device lot number was released meeting all medtronic quality release specifications at the time of manufacture.A review of complaint data reveals no trend for a device related failure for this condition.The reported condition was confirmed.Root cause: the file was concluded to be a misuse by the end user.Replication of the observed conditions may occur if the syringe is not properly engaged with the powder vial cap or the solution is not mixed completely when preparing the product for application.
|